A COVID-19 vaccine setback, departures at the U.S. Chamber of Commerce, and the likely winners under President Joe Biden’s infrastructure plan are among the top business news items this morning.
National
The Food and Drug Administration has asked a manufacturing partner of Johnson & Johnson to temporarily stop its production of COVID-19 vaccine materials while regulators inspect a factory where errors ruined millions of doses. The request marks a further blow for COVID-19 vaccine distribution, as the FDA and Centers for Disease Control recommended that states stop issuing J&J doses due to concerns that they may be linked to rare cases of blood clots.
Several key officials at the U.S. Chamber of Commerce have departed in recent months as the organization changes its leadership and updates its priorities, according to CNBC. Officials did not speak to the network about their reasons for leaving the Chamber, but CNBC noted that the shakeup comes as Republicans have become increasingly critical of the organization for supporting more Democratic lawmakers.
Business trends
UBS Global Wealth Management has identified four sectors it believes will be the key beneficiaries of President Joe Biden’s proposed infrastructure plan. The firm anticipates that green technology, semiconductors, and the industrial and financial sectors would all see significant growth under the plan.
